Details of the Drug
General Information of Drug (ID: DMJRBZF)
| Drug Name |
NG-2
|
||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms |
DG-2; NG2-GAD; Nurel-N1; Glutamic acid decarboxylase-based pain therapy, Diamyd; GAD-based gene therapy (pain, NTDDS),Diamyd; Neurotrophic factor-expressing gene therapies (HSV carrier, neuropathy), Nurel; Neurotrophic factor-expressing gene therapies (HSV carrier, neuropathy/shingles), Diamyd
|
||||||||||||||||||||||
| Indication |
|
||||||||||||||||||||||
| Drug Type |
Small molecular drug
|
||||||||||||||||||||||
| Structure |
![]() |
||||||||||||||||||||||
| 3D MOL | 2D MOL | ||||||||||||||||||||||
| Chemical Identifiers |
|
||||||||||||||||||||||
| Cross-matching ID | |||||||||||||||||||||||

